GIM-122

· Georgiamune Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GIM-122, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies [Phase 1, Phase 2]